Collaborative Clinical Medicines Procurement (CCMP) “Getting Value for Money”. Colette Whigham Category Manager – Pharmacy NHS National Procurement, Scotland Thursday 11 th November 2010. National Procurement.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Collaborative Clinical Medicines Procurement (CCMP) “Getting Value for Money”
Category Manager – Pharmacy
NHS National Procurement, Scotland
Thursday 11th November 2010
Commenced activities in Scotland in 2005 following recommendations made by the McClelland review of public sector procurement.
Purchasing activities across the NHSS historically had been managed:-
In a sporadic manner
Limited coordination across NHS Scotland
Little aggregation of spend across NHS Scotland and more than 23 procurement organisations
Maximise the potential savings by NHS Scotland by sharing the benefits of collaborative buying power. These are realised by the application of best practice strategic sourcing processes and working with suppliers to obtain best value products and services.
Simplify the physical supply chain using managed distribution systems to achieve economies of scale delivered from the National Distribution Centre. (Non Pharmaceuticals)
Coordinate the deployment of world class procurement technology across Health Boards. This offers users access to a variety of tools that support strategic and transactional procurement and enable new methods of collaboration.
Scottish Pharmacologistics Governance Framework
Delivers Savings Consistently
Resistance to and fear of change
Lack of awareness of procurement regulations
Lack of understanding of market dynamics
Lack of clinical resource to implement change
What’s in it for me?
It will take to long!
I don’t have
It’s not my job!!
They won’t fund it
No one asked me
It’s too ambitious
We can’t take the chance
We tried that before
We’ve always done it this way!
We don’t have the staff
We are doing ok as it is!!
I’m all for it, but…
We’ve never done that before
It won’t work in this department
They really don’t want to change
There’s not enough time
It needs more thought
It’s not our problem!!
Diabetes Action Plan – Scottish Government
Hepatitis C Action Plan – Scottish Government
Scottish HIV Action Group - Scottish Government
Scottish Antimicrobial Pharmacy Group
Scottish Radiological Society
Scottish Society for Rheumatology
Scottish Plasma Expert Panel
Scottish Haemophilia Directors
Scottish Cancer Networks
Scottish Fertility Group
Total Parenteral Nutrition Managed Clinical Network
Scottish Neonatal and Paediatric Pharmacists
Scottish Critical Care Pharmacy Group
Scottish Pharmacists Quality Assurance Group
Patient Access Scheme Advisory Group (PASAG)
Communication (Stakeholders and Industry)
Change for sake of change
Well developed specifications
Shared resource (Reduced representation at Clinical Level but endorsed nationally via peer groups)
Thankfully there are not too many of these !!
Low Molecular Weight Heparin – Product Standardisation
Hepatitis C Action Plan – Volume Matrix
Botulinum Toxin Type A – Clinical Substitution without rationalisation
IVF Fertility – Price Normalisation
Insulin Pumps – Ranked Framework
Clozapine – Single Supplier Framework
Homecare – Single Supplier Framework, HIV & Clotting Factors
Blood Glucose Monitoring Strips – Supplier Rationalisation
Contrast Media – Supplier Rationalisation, release market share
G-CSF – Scotland Wide Clinical Input
Gonadorelin Analogues - Clinical Substitution without rationalisation
Total Parenteral Nutrition
Erythropoetin Stimulating Agents
Transitional Medicines – Time to market, when is the right time?
We do not always get it right first time!!
2005/2006 = £4,721,238
2006/2007 = £8,953,191
2007/2008 = £5,873,646
2008/2009 = £5,128,995
2009/2010 = £5,713,346
Total Savings To Date = £ 30,390,416
More complex therapy areas (Work In Progress):
Continued Therapeutic Substitution
Closer collaborative working with Scottish Medicines Consortium (SMC)
Closer collaborative working with National/Health Board Formularies
Continued development of focused Clinical Advisory Panels
No two procurement procedures are the same
Clinical input at the centre of all procurement activity
Savings are a key NHS agenda item
Change management, whilst challenging, is always possible
Future contracts will benefit from lessons learned
Procurement and Clinical resource is essential
Make a plan and stick to it!